FDC per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹19.24₹17.29₹16.39₹18.58₹11.66
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹19.24₹17.29₹16.39₹18.58₹11.66
₹152.64₹152.64₹140.11₹128.81₹119.47
₹140.61₹133.34₹129.48₹119.34₹107.51
—₹12.31₹19.51₹13.56₹9.34
₹0.85₹0.85₹13.56₹7.82₹2.52
—₹4.98₹4.98₹0.01₹0.00
16.316.316.316.316.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FDC₹376.55

FDC Limited

· Pharma & Health
₹ CrorePeersIOLCPMOREPENLABINNOVACAPORCHPHARMASENORESGUJTHEMRPGLIFESANOFIMcap ₹6,131 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS11.6618.5816.3917.2919.24
Diluted EPS11.6618.5816.3917.2919.24
Book Value per Share119.47128.81140.11152.64152.64
Revenue per Share107.51119.34129.48133.34140.61
Cash Flow per Share9.3413.5619.5112.31—
Free Cash Flow per Share2.527.8213.560.850.85
Dividends per Share0.000.014.984.98—
Shares Outstanding (cr)16.616.316.316.316.3
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.